Source link : https://www.newshealth.biz/health-news/fda-advisors-not-convinced-once-weekly-insulin-is-safe-in-type-1-diabetes/
An FDA advisory committee mostly agreed on Friday that an investigational once-weekly insulin product carries too much risk for use in adult patients with type 1 diabetes to recommend approval in this patient population. In a 7-4 vote, the Endocrinologic and Metabolic Drugs Advisory Committee said that Novo Nordisk had not demonstrated that the benefits […]
Author : News Health
Publish date : 2024-05-24 21:42:42
Copyright for syndicated content belongs to the linked Source.